Systemic inflammation in patients with COPD and pulmonary hypertension

P Joppa, D Petrasova, B Stancak, R Tkacova - Chest, 2006 - Elsevier
… with pulmonary hypertension (p = 0.042). … p = 0.011); and log-transformed serum CRP (p =
0.044). In an analogic analysis, log TNF-α was not an independent predictor of systolic Ppa (p

[PDF][PDF] The association between oxidative stress and obstructive lung impairment in patients with COPD.

Z Kluchová, D Petrášová, P Joppa… - Physiological …, 2007 - researchgate.net
An oxidant/antioxidant imbalance is thought to play an important role in the pathogenesis of
chronic obstructive pulmonary disease (COPD). We hypothesized that antioxidant capacity …

Boeing 18-inch fan rig broadband noise test

UW Ganz, PD Joppa, TJ Patten, DF Scharpf - 1998 - ntrs.nasa.gov
The purposes of the subject test were to identify and quantify the mechanisms by which fan
broadband noise is produced, and to assess the validity of such theoretical models of those …

Sarcopenic obesity, functional outcomes, and systemic inflammation in patients with chronic obstructive pulmonary disease

P Joppa, R Tkacova, FME Franssen, C Hanson… - Journal of the American …, 2016 - Elsevier
… (P < .001) and higher total SGRQ score and scores in the symptom, impact, and activity domains
than patients with normal body composition (P … patients with sarcopenia only (P = .024). …

Obstructive sleep apnoea independently predicts lipid levels: data from the European Sleep Apnea Database

…, J Hedner, H Hein, P Joppa, JA Kvamme, P Levy… - …, 2018 - Wiley Online Library
Background and objective Obstructive sleep apnoea (OSA) and dyslipidaemia are independent
risk factors for cardiovascular disease. This study investigates the association between …

Clusters of sleep apnoea phenotypes: a large pan‐European study from the European Sleep Apnoea Database (ESADA)

…, R Tamisier, H Hein, MS Tasbakan, P Joppa… - …, 2021 - Wiley Online Library
Background and objective To personalize OSA management, several studies have attempted
to better capture disease heterogeneity by clustering methods. The aim of this study was to …

[HTML][HTML] Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD

R Tkacova, Z Kluchova, P Joppa, D Petrasova… - Respiratory …, 2007 - Elsevier
… to Stage III and Stage IV groups (p=0.003). In addition, there was a … (p=0.072). PaO 2
decreased, whereas PaCO 2 increased from Stage II to Stage III and Stage IV group (p=0.002 and p

Management of obstructive sleep apnea in Europe–A 10-year follow-up

…, H Gouveris, L Grote, H Hein, P Jennum, P Joppa… - Sleep medicine, 2022 - Elsevier
… has significantly increased to 79% being certified (p=0.043). There is also a significant leap
… , p=0.035) and at least an increasing trend among nursing professionals (from 14% to 50%, p

Oxidativer Stress bei Patienten mit COPD und pulmonaler Hypertonie

P Joppa, D Petrášová, B Stančák, Z Dorková… - Wiener Klinische …, 2007 - Springer
… (P = 0.865). … (P = 0.038) than those without hypertension (Table 1). Blood gas analysis
revealed significantly lower PaO2 in patients with pulmonary hypertension than in those without (P

Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA)

…, MS Tasbakan, G Varoneckas, P Joppa… - Journal of internal …, 2019 - Wiley Online Library
Background and objective Obstructive sleep apnoea (OSA) and hyperlipidaemia are
independent risk factors for cardiovascular disease. This study investigates the association …